Skip to main content
Erschienen in: Diabetologia 1/2014

01.01.2014 | Article

Association between alcohol consumption and plasma fetuin-A and its contribution to incident type 2 diabetes in women

Erschienen in: Diabetologia | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

The benefits of moderate alcohol consumption for type 2 diabetes have been postulated to involve a mechanism of improved insulin sensitivity. Fetuin-A, which is known to inhibit insulin signalling, has emerged as a biomarker for diabetes risk. Alcohol consumption may influence circulating fetuin-A concentrations and subsequently diabetes risk by altering the insulin signal. We therefore hypothesised that moderate alcohol consumption would be associated with lower fetuin-A concentration and that fetuin-A would partly explain the association between alcohol consumption and incident type 2 diabetes.

Methods

Among diabetes-free female participants in the Nurses’ Health Study (n = 1,331), multiple linear regression was conducted to assess the association between alcohol consumption and plasma fetuin-A. Least-squares means (lsmeans) of fetuin-A were estimated in categories of alcohol consumption (0, 0.1–4.9, 5–14.9 and ≥15 g/day). The proportion of alcohol consumption and diabetes association explained by baseline fetuin-A was assessed in 470 matched incident diabetes case–control pairs with follow-up 2000–2006.

Results

Higher alcohol consumption was associated with lower plasma fetuin-A (p for trend = 0.009): lsmean ± SE 476.5 ± 5.9 μg/ml for abstainers, 468.9 ± 5.2 μg/ml for 0.1–4.9 g/day consumers, 455.9 ± 7.0 μg/ml for 5.0–14.9 g/day consumers, and 450.0 ± 9.4 μg/ml for ≥15.0 g/day consumers. Fetuin-A and fasting insulin explained 18.4% and 54.8%, respectively, of the inverse association between alcohol consumption and diabetes after multiple adjustment (both p for contribution <0.04).

Conclusions/interpretation

Moderate alcohol consumption is associated with lower plasma fetuin-A in diabetes-free women. Fetuin-A and insulin explain a significant proportion of the association between alcohol consumption and incident type 2 diabetes. Further studies are needed to examine potential biological mechanisms underlying this association.
Literatur
1.
Zurück zum Zitat Baliunas DO, Taylor BJ, Irving H et al (2009) Alcohol as a risk factor for type 2 diabetes. Diabetes Care 32:2123–2132PubMedCrossRef Baliunas DO, Taylor BJ, Irving H et al (2009) Alcohol as a risk factor for type 2 diabetes. Diabetes Care 32:2123–2132PubMedCrossRef
2.
Zurück zum Zitat Koppes LL, Dekker JM, Hendriks HF, Bouter LM, Heine RJ (2005) Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies. Diabetes Care 28:719–725PubMedCrossRef Koppes LL, Dekker JM, Hendriks HF, Bouter LM, Heine RJ (2005) Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies. Diabetes Care 28:719–725PubMedCrossRef
3.
Zurück zum Zitat Liangpunsakul S, Chalasani N (2012) What should we recommend to our patients with NAFLD regarding alcohol use? Am J Gastroenterol 107:976–978PubMedCrossRef Liangpunsakul S, Chalasani N (2012) What should we recommend to our patients with NAFLD regarding alcohol use? Am J Gastroenterol 107:976–978PubMedCrossRef
4.
Zurück zum Zitat Bonnet F, Disse E, Laville M et al (2012) Moderate alcohol consumption is associated with improved insulin sensitivity, reduced basal insulin secretion rate and lower fasting glucagon concentration in healthy women. Diabetologia 55:3228–3237PubMedCrossRef Bonnet F, Disse E, Laville M et al (2012) Moderate alcohol consumption is associated with improved insulin sensitivity, reduced basal insulin secretion rate and lower fasting glucagon concentration in healthy women. Diabetologia 55:3228–3237PubMedCrossRef
5.
Zurück zum Zitat Sierksma A, Patel H, Ouchi N et al (2004) Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor-alpha, and insulin sensitivity. Diabetes Care 27:184–189PubMedCrossRef Sierksma A, Patel H, Ouchi N et al (2004) Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor-alpha, and insulin sensitivity. Diabetes Care 27:184–189PubMedCrossRef
6.
Zurück zum Zitat Thamer C, Haap M, Fritsche A, Haering H, Stumvoll M (2004) Relationship between moderate alcohol consumption and adiponectin and insulin sensitivity in a large heterogeneous population. Diabetes Care 27:1240PubMedCrossRef Thamer C, Haap M, Fritsche A, Haering H, Stumvoll M (2004) Relationship between moderate alcohol consumption and adiponectin and insulin sensitivity in a large heterogeneous population. Diabetes Care 27:1240PubMedCrossRef
7.
Zurück zum Zitat Sun Q, Cornelis MC, Manson JE, Hu FB (2013) Plasma levels of fetuin-A and hepatic enzymes and risk of type 2 diabetes in women in the U.S. Diabetes 62:49–55PubMedCrossRef Sun Q, Cornelis MC, Manson JE, Hu FB (2013) Plasma levels of fetuin-A and hepatic enzymes and risk of type 2 diabetes in women in the U.S. Diabetes 62:49–55PubMedCrossRef
8.
Zurück zum Zitat Ix JH, Wassel CL, Kanaya AM et al (2008) Fetuin-a and incident diabetes mellitus in older persons. JAMA 300:182–188PubMedCrossRef Ix JH, Wassel CL, Kanaya AM et al (2008) Fetuin-a and incident diabetes mellitus in older persons. JAMA 300:182–188PubMedCrossRef
9.
Zurück zum Zitat Ix JH, Biggs ML, Mukamal KJ et al (2012) Association of fetuin-a with incident diabetes mellitus in community-living older adults: the cardiovascular health study. Circulation 125:2316–2322PubMedCrossRef Ix JH, Biggs ML, Mukamal KJ et al (2012) Association of fetuin-a with incident diabetes mellitus in community-living older adults: the cardiovascular health study. Circulation 125:2316–2322PubMedCrossRef
10.
Zurück zum Zitat Stefan N, Fritsche A, Weikert C et al (2008) Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes 57:2762–2767PubMedCrossRef Stefan N, Fritsche A, Weikert C et al (2008) Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes 57:2762–2767PubMedCrossRef
11.
Zurück zum Zitat Laughlin GA, Barrett-Connor E, Cummins KM, Daniels LB, Wassel CL, Ix JH (2013) The sex-specific association of fetuin-A with type 2 diabetes in older community-dwelling adults: the Rancho Bernardo Study. Diabetes Care 36:1994–2000PubMedCrossRef Laughlin GA, Barrett-Connor E, Cummins KM, Daniels LB, Wassel CL, Ix JH (2013) The sex-specific association of fetuin-A with type 2 diabetes in older community-dwelling adults: the Rancho Bernardo Study. Diabetes Care 36:1994–2000PubMedCrossRef
12.
Zurück zum Zitat Rasul S, Wagner L, Kautzky-Willer A (2012) Fetuin-A and angiopoietins in obesity and type 2 diabetes mellitus. Endocrine 42:496–505PubMedCrossRef Rasul S, Wagner L, Kautzky-Willer A (2012) Fetuin-A and angiopoietins in obesity and type 2 diabetes mellitus. Endocrine 42:496–505PubMedCrossRef
13.
Zurück zum Zitat Goustin A-S, Abou-Samra AB (2011) The “thrifty” gene encoding Ahsg/Fetuin-A meets the insulin receptor: insights into the mechanism of insulin resistance. Cell Signal 23:980–990PubMedCrossRef Goustin A-S, Abou-Samra AB (2011) The “thrifty” gene encoding Ahsg/Fetuin-A meets the insulin receptor: insights into the mechanism of insulin resistance. Cell Signal 23:980–990PubMedCrossRef
14.
Zurück zum Zitat Auberger P, Falquerho L, Contreres JO et al (1989) Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity. Cell 58:631–640PubMedCrossRef Auberger P, Falquerho L, Contreres JO et al (1989) Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity. Cell 58:631–640PubMedCrossRef
15.
Zurück zum Zitat Srinivas PR, Wagner AS, Reddy LV et al (1993) Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level. Mol Endocrinol 7:1445–1455PubMedCrossRef Srinivas PR, Wagner AS, Reddy LV et al (1993) Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level. Mol Endocrinol 7:1445–1455PubMedCrossRef
16.
Zurück zum Zitat Hennige AM, Staiger H, Wicke C et al (2008) Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS ONE 3:e1765PubMedCrossRef Hennige AM, Staiger H, Wicke C et al (2008) Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS ONE 3:e1765PubMedCrossRef
17.
Zurück zum Zitat Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116:1784–1792PubMedCrossRef Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116:1784–1792PubMedCrossRef
18.
Zurück zum Zitat Prentice RL, Breslow NE (1978) Retrospective studies and failure time models. Biometrika 65(1):153–158CrossRef Prentice RL, Breslow NE (1978) Retrospective studies and failure time models. Biometrika 65(1):153–158CrossRef
19.
Zurück zum Zitat Willett WC, Sampson L, Stampfer MJ et al (1985) Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 122:51–65PubMed Willett WC, Sampson L, Stampfer MJ et al (1985) Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 122:51–65PubMed
20.
Zurück zum Zitat Willett W (1998) Nutritional epidemiology. Oxford University Press, New YorkCrossRef Willett W (1998) Nutritional epidemiology. Oxford University Press, New YorkCrossRef
21.
Zurück zum Zitat Fuchs CS, Stampfer MJ, Colditz GA et al (1995) Alcohol consumption and mortality among women. N Engl J Med 332:1245–1250PubMedCrossRef Fuchs CS, Stampfer MJ, Colditz GA et al (1995) Alcohol consumption and mortality among women. N Engl J Med 332:1245–1250PubMedCrossRef
22.
Zurück zum Zitat Giovannucci E, Colditz G, Stampfer MJ et al (1991) The assessment of alcohol consumption by a simple self-administered questionnaire. Am J Epidemiol 133:810–817PubMed Giovannucci E, Colditz G, Stampfer MJ et al (1991) The assessment of alcohol consumption by a simple self-administered questionnaire. Am J Epidemiol 133:810–817PubMed
23.
Zurück zum Zitat Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Hennekens CH, Speizer FE (1987) Moderate alcohol consumption and the risk of breast cancer. N Engl J Med 316:1174–1180PubMedCrossRef Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Hennekens CH, Speizer FE (1987) Moderate alcohol consumption and the risk of breast cancer. N Engl J Med 316:1174–1180PubMedCrossRef
24.
Zurück zum Zitat Rimm EB, Stampfer MJ, Colditz GA, Chute CG, Litin LB, Willett WC (1990) Validity of self-reported waist and hip circumferences in men and women. Epidemiology 1:466–473PubMedCrossRef Rimm EB, Stampfer MJ, Colditz GA, Chute CG, Litin LB, Willett WC (1990) Validity of self-reported waist and hip circumferences in men and women. Epidemiology 1:466–473PubMedCrossRef
25.
Zurück zum Zitat Colditz GA, Martin P, Stampfer MJ et al (1986) Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 123:894–900PubMed Colditz GA, Martin P, Stampfer MJ et al (1986) Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 123:894–900PubMed
26.
Zurück zum Zitat Manson JE, Stampfer MJ, Colditz GA et al (1991) Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet 338:774–778PubMedCrossRef Manson JE, Stampfer MJ, Colditz GA et al (1991) Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet 338:774–778PubMedCrossRef
27.
Zurück zum Zitat McCullough ML, Feskanich D, Stampfer MJ et al (2002) Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr 76:1261–1271PubMed McCullough ML, Feskanich D, Stampfer MJ et al (2002) Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr 76:1261–1271PubMed
28.
Zurück zum Zitat Rosner B, Cook N, Portman R, Daniels S, Falkner B (2008) Determination of blood pressure percentiles in normal-weight children: some methodological issues. Am J Epidemiol 167:653–666PubMedCrossRef Rosner B, Cook N, Portman R, Daniels S, Falkner B (2008) Determination of blood pressure percentiles in normal-weight children: some methodological issues. Am J Epidemiol 167:653–666PubMedCrossRef
29.
Zurück zum Zitat Lin DY, Fleming TR, de Gruttola V (1997) Estimating the proportion of treatment effect explained by a surrogate marker. Stat Med 16:1515–1527PubMedCrossRef Lin DY, Fleming TR, de Gruttola V (1997) Estimating the proportion of treatment effect explained by a surrogate marker. Stat Med 16:1515–1527PubMedCrossRef
30.
Zurück zum Zitat Dunn W, Xu R, Schwimmer JB (2008) Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease. Hepatology 47:1947–1954PubMedCrossRef Dunn W, Xu R, Schwimmer JB (2008) Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease. Hepatology 47:1947–1954PubMedCrossRef
31.
Zurück zum Zitat Gunji T, Matsuhashi N, Sato H et al (2009) Light and moderate alcohol consumption significantly reduces the prevalence of fatty liver in the Japanese male population. Am J Gastroenterol 104:2189–2195PubMedCrossRef Gunji T, Matsuhashi N, Sato H et al (2009) Light and moderate alcohol consumption significantly reduces the prevalence of fatty liver in the Japanese male population. Am J Gastroenterol 104:2189–2195PubMedCrossRef
32.
Zurück zum Zitat Moriya A, Iwasaki Y, Ohguchi S et al (2011) Alcohol consumption appears to protect against non-alcoholic fatty liver disease. Aliment Pharmacol Ther 33:378–388PubMedCrossRef Moriya A, Iwasaki Y, Ohguchi S et al (2011) Alcohol consumption appears to protect against non-alcoholic fatty liver disease. Aliment Pharmacol Ther 33:378–388PubMedCrossRef
33.
Zurück zum Zitat Englund Ögge L, Brohall G, Behre CJ, Schmidt C, Fagerberg B (2006) Alcohol consumption in relation to metabolic regulation, inflammation, and adiponectin in 64-year-old Caucasian women: a population-based study with a focus on impaired glucose regulation. Diabetes Care 29:908–913PubMedCrossRef Englund Ögge L, Brohall G, Behre CJ, Schmidt C, Fagerberg B (2006) Alcohol consumption in relation to metabolic regulation, inflammation, and adiponectin in 64-year-old Caucasian women: a population-based study with a focus on impaired glucose regulation. Diabetes Care 29:908–913PubMedCrossRef
34.
Zurück zum Zitat Joosten MM, Witkamp RF, Hendriks HFJ (2011) Alterations in total and high-molecular-weight adiponectin after 3 weeks of moderate alcohol consumption in premenopausal women. Metabolism 60:1058–1063PubMedCrossRef Joosten MM, Witkamp RF, Hendriks HFJ (2011) Alterations in total and high-molecular-weight adiponectin after 3 weeks of moderate alcohol consumption in premenopausal women. Metabolism 60:1058–1063PubMedCrossRef
35.
Zurück zum Zitat Beulens JWJ, Rimm EB, Hu FB, Hendriks HFJ, Mukamal KJ (2008) Alcohol consumption, mediating biomarkers, and risk of type 2 diabetes among middle-aged women. Diabetes Care 31:2050–2055PubMedCrossRef Beulens JWJ, Rimm EB, Hu FB, Hendriks HFJ, Mukamal KJ (2008) Alcohol consumption, mediating biomarkers, and risk of type 2 diabetes among middle-aged women. Diabetes Care 31:2050–2055PubMedCrossRef
36.
Zurück zum Zitat Nielsen SJ, Kit BK, Fakhouri T, Ogden CL (2012) Calories consumed from alcoholic beverages by U.S. adults, 2007–2010. NCHS Data Brief 110:1–8PubMed Nielsen SJ, Kit BK, Fakhouri T, Ogden CL (2012) Calories consumed from alcoholic beverages by U.S. adults, 2007–2010. NCHS Data Brief 110:1–8PubMed
37.
Zurück zum Zitat Chrostek L, Jelski W, Szmitkowski M, Puchalski Z (2003) Gender-related differences in hepatic activity of alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in humans. J Clin Lab Anal 17:93–96PubMedCrossRef Chrostek L, Jelski W, Szmitkowski M, Puchalski Z (2003) Gender-related differences in hepatic activity of alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in humans. J Clin Lab Anal 17:93–96PubMedCrossRef
38.
Zurück zum Zitat Kotsopoulos J, Tworoger SS, Campos H et al (2010) Reproducibility of plasma and urine biomarkers among premenopausal and postmenopausal women from the Nurses’ Health Studies. Cancer Epidemiol Biomarkers Prev 19:938–946PubMedCrossRef Kotsopoulos J, Tworoger SS, Campos H et al (2010) Reproducibility of plasma and urine biomarkers among premenopausal and postmenopausal women from the Nurses’ Health Studies. Cancer Epidemiol Biomarkers Prev 19:938–946PubMedCrossRef
Metadaten
Titel
Association between alcohol consumption and plasma fetuin-A and its contribution to incident type 2 diabetes in women
Publikationsdatum
01.01.2014
Erschienen in
Diabetologia / Ausgabe 1/2014
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-013-3077-8

Weitere Artikel der Ausgabe 1/2014

Diabetologia 1/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.